We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Engineered T Cells Promote Long-term Organ Transplant Acceptance
News

Engineered T Cells Promote Long-term Organ Transplant Acceptance

Engineered T Cells Promote Long-term Organ Transplant Acceptance
News

Engineered T Cells Promote Long-term Organ Transplant Acceptance

Scanning electron microscopy image of engineered T cells lacking coronin 1. Image credit: Swiss Nanoscience Institute/University of Basel, Biozentrum
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Engineered T Cells Promote Long-term Organ Transplant Acceptance"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of Basel’s Biozentrum have now discovered a molecular approach to preventing rejection of the transplanted graft while simultaneously maintaining the ability to fight against infections.

When someone is confronted with ‘foreign’ material, be it viruses, bacteria, fungi, but also donor organs following transplantation, immune cells called T cells come into action to inactivate and destroy the ‘foreign’ material. Prof. Jean Pieters’ team at the Biozentrum of the University of Basel together with collaborating scientists have now described a way to selectively suppress the immune reaction of the body against the donor organ by modulating the protein coronin 1.

By blocking this protein in T cells, these immune cells do not attack the transplanted organ anymore. However, the T cells continue to keep viruses, bacteria and fungal infections in check. These findings could potentially provide new approaches for reducing graft rejection in the future.

Engineered T cells prevent organ rejection but still fight infections

Coronin 1 is a protein that regulates T cells, which are essential for detecting and destroying invaders of the body. These T cells also recognize a transplanted organ as foreign. In a mouse model, the team has now been able to relate these graft rejections by T cells to coronin 1.

“By removing coronin 1, we observed that the T cells not only massively suppressed the immune response to the transplanted organ but even actively prevented its rejection,” says first author Rajesh Jayachandran. “At the same time, we were astonished that coronin 1-depleted T cells continue to fight infections.”

Finding a tolerance pathway for organ transplantation

The lab of Jean Pieters originally defined coronin 1 as a host factor hijacked by pathogens to survive within immune cells. The new research shows that in T cells, coronin 1 modulates a signaling pathway that produces the so-called ‘second messenger’ molecule cAMP. In the absence of coronin 1, cAMP levels drastically increase in T cells, thereby making these cells tolerogenic to the transplanted organ.

However, the group found that when challenged with microbial infections, there is still a way to stimulate T cells to control infections, since microbes induce the expression of certain molecules that neutralize the cAMP-mediated suppression.

Immune defense manipulation for organ transplantation?

The new findings have now demonstrated a way of manipulating the body’s immune response by selectively suppressing the immune response of the host. Whether these findings may result in the development of therapies to allow retention of transplanted organs while retaining the ability to fight infections remains a task for the future.

This article has been republished from materials provided by the University of Basel. Note: material may have been edited for length and content. For further information, please contact the cited source.

Reference:

Jayachandran, R., Gumienny, A., Bolinger, B., Ruehl, S., Lang, M. J., Fucile, G., . . . Pieters, J. (2019). Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity. Immunity. doi:10.1016/j.immuni.2018.12.011

Advertisement